About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT03938948

Low Level Light Therapy (LLLT) for Hair Growth

A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session ...

Lead sponsor: Awareable Technologies Inc•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Elinor Chang

CONTACT

7134876230 admin@awareable.ai

Sponsors

Lead Sponsor

Awareable Technologies Inc

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male or female subjects between the ages of 18 and 60 years
•Diagnosed AGA in the past 12 months for male (Fitzpatrick I-IV, Hamilton-Norwood IIa-V ) and female (Fitzpatrick I-IV, and Ludwig-Savin Baldness Scale I-2, I-3, I-4, II-1, II-2 baldness patterns)

Exclusion Criteria

•Known Photosensitivity
•Using any oral or topical substance for hair growth
•Having Tattoo, hair transplantation, scalp reduction, malignancy or hair weave in the scalp are with alopecia
•Known medical conditions that could negatively affect hair growth, such as infections, connective tissue disease
•Currently or plan to be on a calorie-restricted diet during study participation

Related studies

Active Not RecruitingPhase 2

Safety and Efficacy of VDPHL01 in Males and Females With AGA

NCT06527365 · Androgenetic Alopecia, AGA, and more

Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss

NCT05970809 · Male Pattern Baldness, Androgenetic Alopecia, and more

Not Yet RecruitingPhase 3

Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

NCT05824065 · Female Pattern Baldness

WITHDRAWNPhase 2

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

NCT03852992 · Male Pattern Hair Loss, Androgenetic Alopecia, and more

Effect of the Composition From Fish on Promoting Hair Growth

NCT05450861 · Hair Loss/Baldness, Androgenic Alopecia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 1, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment62

Start dateApr 2019

Last updatedJun 1, 2021

Condition

Male Pattern Baldness Female Pattern Baldness

Locations shown

Will Surgical Arts

Ijamsville, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 1, 2021Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions